Regeneron and Sanofi explore expanded partnership for Dupixent follow-on candidates
read at Endpoints ↗DealPositive
Regeneron and Sanofi said they are in early discussions about expanding their collaboration beyond the existing Dupixent partnership.
The companies indicated the potential scope could include development of follow-on products that build on Dupixent's platform, though details remain limited.
Both CEOs emphasized that the partnership has been one of the most productive in recent years, and they will continue to explore opportunities as they arise.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Regeneron, Sanofi tease potential expanded collaboration for Dupixent follow-ons”
read at Endpoints ↗90 words · retrieved Jul 30
comments(0)
5-min edit window · permanent after that